☰

Puneet Opal, MD, PhD - Publications

Affiliations: 
Northwestern University, Evanston, IL 
Area:
Neurodegeneration, Neurology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Luttik K, Tejwani L, Ju H, Driessen T, Smeets CJLM, Edamakanti CR, Khan A, Yun J, Opal P, Lim J. Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1. Proceedings of the National Academy of Sciences of the United States of America. 119: e2208513119. PMID 35969780 DOI: 10.1073/pnas.2208513119  0.637
2020 Edamakanti CR, Opal P. Purification of Prominin-1+ Stem Cells from Postnatal Mouse Cerebellum. Journal of Visualized Experiments : Jove. PMID 32338650 DOI: 10.3791/60554  0.338
2019 Didonna A, Opal P. The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders. Molecular Neurodegeneration. 14: 19. PMID 31097008 DOI: 10.1186/s13024-019-0318-4  0.388
2019 Hu YS, Do J, Edamakanti CR, Kini AR, Martina M, Stupp SI, Opal P. Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1. Brain : a Journal of Neurology. PMID 30649233 DOI: 10.1093/Brain/Awy328  0.313
2018 Frederick NM, Shah PV, Didonna A, Langley MR, Kanthasamy AG, Opal P. Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes. Human Molecular Genetics. PMID 30590536 DOI: 10.1093/Hmg/Ddy433  0.402
2018 Murmann AE, Yu J, Opal P, Peter ME. Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer. Trends in Cancer. 4: 684-700. PMID 30292352 DOI: 10.1016/J.Trecan.2018.08.004  0.367
2018 Edamakanti CR, Do J, Didonna A, Martina M, Opal P. Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1. The Journal of Clinical Investigation. PMID 29533923 DOI: 10.1172/Jci96765  0.431
2018 Yang X, Lu B, Sun X, Han C, Fu C, Xu K, Wang M, Li D, Chen Z, Opal P, Wen Q, Crispino JD, Wang QF, Huang Z. ANP32A regulates histone H3 acetylation and promotes leukemogenesis. Leukemia. PMID 29467488 DOI: 10.1038/S41375-018-0010-7  0.391
2016 Lin NH, Huang YS, Opal P, Goldman RD, Messing A, Perng MD. The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP. Molecular Biology of the Cell. PMID 27798231 DOI: 10.1091/Mbc.E16-06-0362  0.433
2016 Didonna A, Opal P. Advances in Sequencing Technologies for Understanding Hereditary Ataxias: A Review. Jama Neurology. PMID 27749953 DOI: 10.1001/jamaneurol.2016.3097  0.3
2016 Venkatraman A, Opal P. Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review. Annals of Clinical and Translational Neurology. 3: 655-63. PMID 27606347 DOI: 10.1002/acn3.328  0.312
2016 Cvetanovic M, Hu YS, Opal P. Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1. Cerebellum (London, England). PMID 27306906 DOI: 10.1007/S12311-016-0794-9  0.685
2016 Israeli E, Dryanovski DI, Schumacker PT, Chandel NS, Singer JD, Julien JP, Goldman RD, Opal P. Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in Giant Axonal Neuropathy. Human Molecular Genetics. PMID 27000625 DOI: 10.1093/Hmg/Ddw081  0.386
2015 Lowery J, Jain N, Kuczmarski ER, Mahammad S, Goldman A, Gelfand VI, Opal P, Goldman RD. Abnormal Intermediate Filament Organization Alters Mitochondrial Motility in Giant Axonal Neuropathy Fibroblasts. Molecular Biology of the Cell. PMID 26700320 DOI: 10.1091/Mbc.E15-09-0627  0.328
2015 Dell'Orco JM, Wasserman AH, Chopra R, Ingram MA, Hu YS, Singh V, Wulff H, Opal P, Orr HT, Shakkottai VG. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 11292-307. PMID 26269637 DOI: 10.1523/Jneurosci.1357-15.2015  0.359
2015 Didonna A, Opal P. The promise and perils of HDAC inhibitors in neurodegeneration. Annals of Clinical and Translational Neurology. 2: 79-101. PMID 25642438 DOI: 10.1002/acn3.147  0.384
2015 Cvetanovic M, Ingram M, Orr H, Opal P. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience. 289: 289-99. PMID 25595967 DOI: 10.1016/J.Neuroscience.2015.01.003  0.675
2014 Venkatraman A, Hu YS, Didonna A, Cvetanovic M, Krbanjevic A, Bilesimo P, Opal P. The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1. Human Molecular Genetics. 23: 3733-45. PMID 24594842 DOI: 10.1093/Hmg/Ddu081  0.703
2013 Mahammad S, Murthy SN, Didonna A, Grin B, Israeli E, Perrot R, Bomont P, Julien JP, Kuczmarski E, Opal P, Goldman RD. Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. The Journal of Clinical Investigation. 123: 1964-75. PMID 23585478 DOI: 10.1172/Jci66387  0.415
2013 Opal P, Zoghbi H. The Hereditary Ataxias Emery and Rimoin's Principles and Practice of Medical Genetics. 1-32. DOI: 10.1016/B978-0-12-383834-6.00125-7  0.41
2012 Cvetanovic M, Kular RK, Opal P. LANP mediates neuritic pathology in Spinocerebellar ataxia type 1. Neurobiology of Disease. 48: 526-32. PMID 22884877 DOI: 10.1016/J.Nbd.2012.07.024  0.707
2011 Cvetanovic M, Patel JM, Marti HH, Kini AR, Opal P. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1. Nature Medicine. 17: 1445-7. PMID 22001907 DOI: 10.1038/Nm.2494  0.655
2010 Kular RK, Gogliotti RG, Opal P. Cpd-1 null mice display a subtle neurological phenotype. Plos One. 5. PMID 20844742 DOI: 10.1371/Journal.Pone.0012649  0.388
2009 Kular RK, Cvetanovic M, Siferd S, Kini AR, Opal P. Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex. The Journal of Biological Chemistry. 284: 7783-92. PMID 19136565 DOI: 10.1074/Jbc.M806150200  0.694
2007 Cvetanovic M, Rooney RJ, Garcia JJ, Toporovskaya N, Zoghbi HY, Opal P. The role of LANP and ataxin 1 in E4F-mediated transcriptional repression. Embo Reports. 8: 671-7. PMID 17557114 DOI: 10.1038/Sj.Embor.7400983  0.71
2007 Paganoni S, Naidech AM, Opal P. Huntington's disease presenting as postsurgical psychosis. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1209-10. PMID 17443707 DOI: 10.1002/Mds.21522  0.307
2004 Opal P, Garcia JJ, McCall AE, Xu B, Weeber EJ, Sweatt JD, Orr HT, Zoghbi HY. Generation and characterization of LANP/pp32 null mice. Molecular and Cellular Biology. 24: 3140-9. PMID 15060138 DOI: 10.1128/Mcb.24.8.3140-3149.2004  0.554
2003 Opal P, Garcia JJ, Propst F, Matilla A, Orr HT, Zoghbi HY. Mapmodulin/leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis. The Journal of Biological Chemistry. 278: 34691-9. PMID 12807913 DOI: 10.1074/Jbc.M302785200  0.569
2002 Opal P, Zoghbi HY. The role of chaperones in polyglutamine disease. Trends in Molecular Medicine. 8: 232-6. PMID 12067633 DOI: 10.1016/S1471-4914(02)02310-9  0.561
2001 Cummings CJ, Sun Y, Opal P, Antalffy B, Mestril R, Orr HT, Dillmann WH, Zoghbi HY. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Human Molecular Genetics. 10: 1511-8. PMID 11448943 DOI: 10.1093/Hmg/10.14.1511  0.595
Show low-probability matches.